Tri Locum Partners LP — 13F holdings
Tri Locum Partners LP reported 19 holdings worth $813M in its 13F filing for Q2 2026, filed August 14, 2026.
Largest positions
- JNJ JOHNSON & JOHNSON — $108M (13.3%)
- VRTX VERTEX PHARMACEUTICALS INC — $100M (12.3%)
- LLY ELI LILLY & CO — $91.8M (11.3%)
- ASND Ascendis Pharma A/S — $69.0M (8.5%)
- DXCM DEXCOM INC — $55.3M (6.8%)
- AXSM AXSOME THERAPEUTICS INC — $53.7M (6.6%)
- JAZZ JAZZ PHARMACEUTICALS PLC — $53.4M (6.6%)
- ELVN ENLIVEN THERAPEUTICS INC — $44.0M (5.4%)
- ARGX ARGENX SE — $38.6M (4.7%)
- MDGL MADRIGAL PHARMACEUTICALS INC — $36.7M (4.5%)